Results by work areas
Home > Areas
The drug phenomenon has a global dimension that makes it necessary to strengthen international collaboration between the EU, Latin America and Caribbean countries.
In line with the European Drug Strategy (2021–2025), both regional and national actions of the programme are based on shared principles: joint responsibility, multilateralism, development approach, respect for human rights and dignity, strengthening of the rule of law and compliance with international drug control conventions.
The COPOLAD III programme aims to promote bi-regional technical cooperation on drug policies, and these are the main results achieved in its areas of work.
In line with the European Drug Strategy (2021–2025), both regional and national actions of the programme are based on shared principles: joint responsibility, multilateralism, development approach, respect for human rights and dignity, strengthening of the rule of law and compliance with international drug control conventions.
The COPOLAD III programme aims to promote bi-regional technical cooperation on drug policies, and these are the main results achieved in its areas of work.
National Drug Observatories
Generating empirical evidence to design better policies
VIEW MORE
Drug demand reduction policies
Promoting rights-based, gender-sensitive and socially inclusive approaches in care services for highly vulnerable communities
VIEW MORE
Fight against drug trafficking
Strengthening police investigation systems, financial investigation into money laundering and social reuse of confiscated assets
VIEW MORE
Comprehensive and Sustainable Alternative Development (AD)
Breaking the dependency of drug economies
VIEW MORE
Control of chemical precursors
Strengthening the comprehensive chain of control, management and final disposal
VIEW MORE
Proporcionality and alternative penal sanctions
Promoting a more humane criminal response that protects the rights of women and vulnerable groups linked to minor drug crimes
VIEW MORE
EU-CELAC bi-regional dialogue on drug policies
Strenghtening technical and political bridges in the face of a common challenge
VIEW MORE